All articles tagged with #stock slump
PayPal is drawing preliminary takeover interest from potential buyers after a slide in its shares, with Bloomberg noting some suitors are exploring the whole company while others are eyeing specific assets. A deal is not guaranteed. The company—worth over $38 billion—has seen leadership changes and warned of slower growth amid competition from Big Tech and weaker retail spending, with its stock up about 7% on the Bloomberg report.
Novo Nordisk warned profits and sales could fall as much as 13% due to unprecedented price pressure on GLP-1 weight‑loss drugs, amplified by a U.S. government price deal. The news sparked an about 18% drop in the stock as the company grapples with competition from Eli Lilly, patent expiries, and ongoing cost-cutting, with CEO Maziar Doustdar saying the cuts are painful but intended to broaden access and drive future growth.
BYD's shares in China declined following a significant drop in Q2 profits, contrasting with Tesla's performance, highlighting challenges faced by Chinese EV rivals amid market fluctuations.
Shares of Trump Media & Technology Group, the parent company of Truth Social, slumped over 20% as the initial excitement surrounding its public debut faded, resulting in a $2 billion decrease in market value. Despite the drop, the company's value remained higher than before its merger with a public shell company. Trump Media's revenue, primarily from advertising on Truth Social, was revealed to be $750,000 in the fourth quarter of last year, with a full-year total of $4.1 million and a $58 million loss in 2023.
Boeing's stock slump has surpassed 25% this year as the Justice Department opens a criminal investigation into an accident involving an Alaska Airlines 737 Max flight. The investigation deepens the crisis surrounding the company, which has faced increased scrutiny from regulators, legislators, and the public. The incident, along with a string of unrelated aviation incidents, has put pressure on Boeing's safety practices and manufacturing quality. The company's cooperation with investigations and its overall safety culture are under scrutiny, as regulators aim to define milestones with Boeing over the next 30 days.
Activist investors Trian Group and Blackwells Capital are pressuring Disney ahead of its first-quarter financial results, with proposals including board seat nominations and suggestions to divide the company. Disney is also focusing on turning ESPN into a digital sports platform and exploring strategic partnerships for the network. The company's stock price has remained flat during CEO Bob Iger's tenure, in contrast to gains seen by other NASDAQ stocks, and has dropped 10% in the past year due to losses in the streaming division, box office failures, and issues at theme parks.
ChargePoint Holdings' stock plummeted by nearly 38% to a record low after the electric vehicle charging network reduced its third-quarter revenue forecast due to weak demand caused by delays in electric vehicle deliveries. The company also announced the replacement of its CEO and CFO. Multiple analysts have slashed their price targets and downgraded their ratings on ChargePoint's stock, reflecting concerns about the near-term outlook for the company and the broader EV charging industry.
Citigroup CEO Jane Fraser has announced a corporate reorganization aimed at cutting down management layers and accelerating decision-making. The move comes as the bank is facing a stock slump. The reorganization will include job cuts, although the exact number has not been determined yet.
Medical Properties Trust (MPW) stock dropped 7.7% after a report revealed that a California regulator has put on hold a deal to save one of its largest tenants, Prospect Medical. The deal involved Prospect securing $375 million in new financing from third-party lenders, with MPW receiving a stake in return. The regulator's order, issued on July 20, has not been disclosed by MPW in its recent earnings report or filing. However, MPW remains confident that the deal will gain approval, stating that the regulatory review process is normal and expected.
Tyson Foods' stock slumped after reporting lower-than-expected earnings and revenue, partly due to the closure of chicken facilities, which resulted in a significant quarterly impairment charge.
Nvidia's stock slumps as new U.S. rules on exporting AI chips to China could potentially impact the company's shipments to China, leading to a significant financial blow for Nvidia and other chip makers amidst escalating tensions in the technology Cold War.
Regeneron Pharmaceuticals' stock slumped after the FDA rejected its application for approval of a higher-dose version of its popular eye disease treatment, Eylea.